Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hera Diagnostics
AddedFeb 18, 2024
UpdatedJun 18, 2026
Hera Diagnostics

Hera Diagnostics

Seed

Hera Diagnostics: Innovating portable, real-time cancer screening devices for home and remote use.

HQ
McAllen, TX, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Hera Diagnostics, founded with a mission to eliminate healthcare barriers, focuses on creating innovative diagnostic instruments for rapid cancer screening. Their core vision is to provide affordable, accessible, and inclusive healthcare solutions worldwide. Specializing in portable screening devices for cervical, skin, throat, and stomach cancers, Hera Diagnostics aims to reach patients at home or in remote areas, enabling real-time illness confirmation without the need for biopsies.

Notable figures associated with Hera Diagnostics include experts in optical and electrical spectroscopy and artificial intelligence. The company has garnered attention from investors committed to advancing healthcare technology. Key achievements include the development of sophisticated AI algorithms that enhance the accuracy and speed of their diagnostic tools. Hera Diagnostics' impact lies in its potential to revolutionize cancer screening, particularly for underserved populations, by making life-saving diagnostics more accessible and efficient.

Hera Diagnostics - Quick Facts

When was Hera Diagnostics founded?

Hera Diagnostics was founded in 2020.

Where is Hera Diagnostics' headquarters located?

Hera Diagnostics' headquarters is located in McAllen, TX, US.

When was Hera Diagnostics' last funding round?

Hera Diagnostics' most recent funding round was for $898.3k (USD) in December 2022.

How much has Hera Diagnostics raised to-date?

As of Dec 2, 2022, Hera Diagnostics has raised a total of $898.3k (USD).

How many employees does Hera Diagnostics have?

Hera Diagnostics has 30 employees as of Feb 5, 2024.

Hera Diagnostics - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified